This week, Isabel interviews Hideki Garren, Senior Vice President and Global Head of Clinical Development, Neurology, Roche, about the changing landscape of multiple sclerosis care and its implications for patients.
Garren, appointed in September 2024, has led global neuroimmunology development at Roche. Previously, he served as Chief Medical Officer at Prothena Biosciences and held leadership roles at Coya Therapeutics, Novartis, and Bayhill Therapeutics, which he co-founded. He completed his neurology residency and postdoctoral fellowship at Stanford University and holds a bachelor’s degree from Caltech and an MD and PhD from UCLA.